The best part in language one can fully understand. :o)

"Analysis of BETonMACE and insight into the trial’s implications on BET inhibition as a strategy for atherosclerotic complications awaits full publication. The Food and Drug Administration recently granted Breakthrough Therapy Designation for apabetalone, a status designed for expediting drugs that have preliminary clinical evidence indicating a potential substantial improvement over available therapy on clinically significant end point."

Koo